SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes.

ABSTRACT:

Objective

To examine the impact of SARS-CoV-2 on long-term glycemia.

Research design and methods

We conducted a retrospective inception cohort study using Veterans Health Administration data (March 1, 2020-May 31, 2022) among individuals with ≥ 1 positive nasal swab for SARS-CoV-2 and individuals with ≥ 1 laboratory test of any type but no positive swab. Two incident diabetes cohorts were defined based on: 1) a computable phenotype using a combination of diagnosis codes, laboratory tests, and receipt of glucose-lowering medications (n = 17,754); and 2) the presence of ≥ 2 HbA1c results ≥ 6.5% (n = 4,768). We fit log-binomial models examining associations of SARS-CoV-2 with diabetes remission, defined as ≥ 2 HbA1c measurements < 6.5% ≥ 90 days apart after cessation of any glu

SUBMITTER: Wander PL 

PROVIDER: S-EPMC11838867 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature